Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Adverum Biotechnologies, Inc (ADVM)  
$2.32 0.17 (6.83%) as of 4:30 Fri 6/27


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 101,000,000
Market Cap: 234.32(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $2.05 - $9.48
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    : 12.4
Insider 6 Months    : 17
Insider 3/6 Months : 29.8
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Adverum Biotechnologies is a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases. Co.'s primary product candidate, ADVM-022, is a single, in-office intravitreal (IVT) injection gene therapy product. ADVM-022 is being developed for the treatment of patients with wet age-related macular degeneration who are responsive to anti-vascular endothelial growth factor therapy. Co.'s second product candidate, ADVM-062 (AAV.7m8-L-opsin), is a gene therapy product candidate being developed to deliver a functional copy of the OPN1LW gene to the foveal cones of patients suffering from blue cone monochromacy via a single IVT injection.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 384,775 893,065 1,195,129 1,425,129
Total Buy Value $1,196,026 $3,497,708 $5,896,840 $6,207,340
Total People Bought 1 1 1 3
Total Buy Transactions 4 13 16 18
Total Shares Sold 13,010 29,603 29,603 35,804
Total Sell Value $26,020 $112,109 $112,109 $121,538
Total People Sold 3 4 4 4
Total Sell Transactions 3 4 4 5
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 184
  Page 1 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Seyedkazemi Setareh CHIEF DEVELOPMENT OFFICER   •       –      –    2025-05-15 4 S $2.00 $1,848 D/D (924) 13,768 -13%     
   Fischer Laurent CEO, PRESIDENT AND DIRECTOR   •       •      –    2025-05-15 4 S $2.00 $18,252 D/D (9,126) 87,488 -13%     
   Soparkar Peter CHIEF OPERATING OFFICER   •       –      –    2025-05-15 4 S $2.00 $5,920 D/D (2,960) 39,154 -13%     
   Leonard Braden Michael   •       •       •   2025-04-23 4 B $2.98 $148,950 D/D 50,000 191,800 0.01 -19%     
   Leonard Braden Michael   •       •       •   2025-04-22 4 B $3.00 $900,000 I/I 300,000 3,057,526 0.01 -22%     
   Leonard Braden Michael   •       •       •   2025-04-02 4 B $4.04 $61,408 I/I 15,209 2,757,526 0.01 -46%     
   Leonard Braden Michael   •       •       •   2025-03-31 4 B $4.38 $85,668 I/I 19,566 2,742,317 0.01 -47%     
   Leonard Braden Michael   •       •       •   2025-03-27 4 B $5.19 $86,089 D/D 16,593 141,800 0.01 -53%     
   Leonard Braden Michael   •       •       •   2025-03-27 4/A B $5.19 $86,089 D/D 16,593 141,800 0.01     -
   Leonard Braden Michael   •       •       •   2025-03-27 4 S $5.19 $86,089 D/D (16,593) 141,800 53%     
   Leonard Braden Michael   •       •       •   2025-03-26 4 B $5.04 $102,841 D/D 20,407 125,207 0.01 -54%     
   Leonard Braden Michael   •       •       •   2025-03-20 4 B $5.61 $171,767 I/I 30,600 2,722,761 0.01 -59%     
   Leonard Braden Michael   •       •       •   2025-03-19 4 B $4.94 $123,390 I/I 25,000 2,692,161 0.01 -57%     
   Leonard Braden Michael   •       •       •   2025-03-18 4 B $4.60 $292,418 I/I 62,341 2,667,161 0.01 -53%     
   Leonard Braden Michael   •       •       •   2025-02-28 4 B $4.60 $391,015 I/I 85,068 2,604,820 0.01 -51%     
   Leonard Braden Michael   •       •       •   2025-02-27 4 B $4.46 $387,094 I/I 86,802 2,519,752 0.01 -47%     
   Leonard Braden Michael   •       •       •   2025-02-26 4 B $4.01 $660,979 I/I 164,886 2,432,950 0.01 -45%     
   Seyedkazemi Setareh CHIEF DEVELOPMENT OFFICER   •       –      –    2025-02-25 4 A $0.00 $0 D/D 8,125 14,692     -
   Ozden Rabia Gurses Chief Medical Officer   •       –      –    2025-02-25 4 A $0.00 $0 D/D 8,125 8,125     -
   Fischer Laurent CEO, PRESIDENT AND DIRECTOR   •       •      –    2025-02-25 4 A $0.00 $0 D/D 25,000 96,614     -
   Soparkar Peter CHIEF OPERATING OFFICER   •       –      –    2025-02-25 4 A $0.00 $0 D/D 13,125 42,114     -
   Rubinstein Linda M CHIEF FINANCIAL OFFICER   •       –      –    2025-02-25 4 A $0.00 $0 D/D 8,125 19,325     -
   Leonard Braden Michael   •       •       •   2024-07-30 4 B $7.15 $613,470 I/I 85,800 2,268,064 0.01 -20%     
   Leonard Braden Michael   •       •       •   2024-07-18 4 B $9.11 $735,736 I/I 80,718 2,182,264 0.01 -35%     
   Leonard Braden Michael   –       –       •   2024-07-17 3 IO $0.00 $0 D/D 0 104,800 -31%     

  184 Records found
  1  2  3  4  5  6  7  8   
  Page 1 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed